Abiopharma

New SEC Form for ResMed Inc.

New Form 4 - Fortive Corp Filed: 2025-08-04 AccNo: 0001659166-25-000122 Size: 5 KB

New Form SCHEDULE 13D/A - Cyclacel Pharmaceuticals, Inc. Filed: 2025-08-04 AccNo: 0000921895-25-002083 Size: 10 KB

New Form 4 - Cyclacel Pharmaceuticals, Inc. Filed: 2025-08-04 AccNo: 0000921895-25-002082 Size: 5 KB

New Form 4 - Amphastar Pharmaceuticals, Inc. Filed: 2025-08-04 AccNo: 0001415889-25-020987 Size: 5 KB

New Form 4 - Guardant Health, Inc. Filed: 2025-08-04 AccNo: 0001576280-25-000248 Size: 6 KB

CYCLACEL PHARMACEUTICALS HIGHLIGHTS PRECLINICAL DATA SHOWING THAT CANCER OF THE BILIARY TRACT IS SENSITIVE TO PLOGOSERTIB

iSpecimen Inc. Announces Closing of Approximately $1.75 Million Private Placement Priced At-the-Market

ResMed Inc. Daily Stock Update

New Form 4 - Larimar Therapeutics, Inc. Filed: 2025-08-04 AccNo: 0001193805-25-001155 Size: 36 KB

New Form SCHEDULE 13G/A - Forte Biosciences, Inc. Filed: 2025-08-04 AccNo: 0000929638-25-002878 Size: 14 KB

New Form 4 - Orchestra BioMed Holdings, Inc. Filed: 2025-08-04 AccNo: 0001104659-25-073743 Size: 8 KB

New Form 144 - Vor Biopharma Inc. Filed: 2025-08-04 AccNo: 0001950047-25-005423 Size: 4 KB

DEADLINE NEXT WEEK: Rocket Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Securities Class Action Lawsuit

New Form SCHEDULE 13G - ProMIS Neurosciences Inc. Filed: 2025-08-04 AccNo: 0001641172-25-022106 Size: 29 KB